Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
LakeShore Biopharma Co. Ltd Warrants (OTC : LSBPW) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China.
Quote
| Last: | $ |
|---|---|
| Change Percent: | |
| Open: | $ |
| Close: | $ |
| High: | $ |
| Low: | $ |
| Volume: | 0 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Stock Data
| Market Cap: | $1,088,253,271 |
|---|---|
| Float: | 10,014,684 |
| Insiders Ownership: | N/A |
| Institutions: | 2 |
| Short Percent: | 1866% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.investors.lakeshorebio.com |
| Country: | CN |
| City: | Beijing |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about LakeShore Biopharma Co. Ltd Warrants (OTC: LSBPW).
